Levofloxacin's Coverage Against Anaerobic Bacteria
Levofloxacin (Levaquin) provides limited coverage against anaerobic bacteria and should not be used as monotherapy when anaerobic coverage is required. 1, 2
Anaerobic Activity Profile
Levofloxacin's activity against anaerobes can be characterized as follows:
Limited anaerobic coverage: Levofloxacin exhibits only moderate activity against some anaerobic pathogens and poor activity against others, particularly those found in intra-abdominal infections 1
Bacteroides fragilis coverage: Levofloxacin has limited activity against B. fragilis (MIC90 = 2-4 μg/mL) and even poorer activity against non-fragilis Bacteroides species 1
Selective anaerobic activity: While it may show some activity against anaerobes associated with sinusitis and soft tissue infections, its overall anaerobic spectrum is inadequate for serious anaerobic infections 1
Comparison to Other Fluoroquinolones
Fluoroquinolones vary significantly in their anaerobic coverage:
Low anaerobic activity group: Ciprofloxacin, ofloxacin, levofloxacin, fleroxacin, pefloxacin, enoxacin, and lomefloxacin 2
Intermediate anaerobic activity: Sparfloxacin and grepafloxacin 2
Higher anaerobic activity: Moxifloxacin, trovafloxacin, gatifloxacin 2
Strongest anaerobic activity: Clinafloxacin and sitafloxacin 2
Clinical Implications
When treating infections with potential anaerobic involvement:
Intra-abdominal infections: Guidelines recommend moxifloxacin as a fluoroquinolone option for intra-abdominal infections due to its superior anaerobic coverage compared to levofloxacin 3
Combination therapy needed: When using levofloxacin in mixed aerobic/anaerobic infections, it should be combined with an agent with reliable anaerobic activity such as metronidazole 1
Synergistic potential: Levofloxacin does not antagonize the activity of clindamycin or metronidazole and may provide additive or synergistic effects against some anaerobes when used in combination 1
Treatment Recommendations
For infections where anaerobic coverage is essential:
Use an alternative fluoroquinolone: Consider moxifloxacin which has documented activity against both aerobic and anaerobic bacteria 3
Add metronidazole: If using levofloxacin for its gram-positive and gram-negative coverage, add metronidazole for anaerobic coverage 3
Consider combination therapy: For serious mixed infections, combination therapy with agents specifically targeting anaerobes is recommended 3
Common Pitfalls
Monotherapy misconception: Using levofloxacin alone for infections with significant anaerobic involvement can lead to treatment failure
Inappropriate substitution: Assuming all fluoroquinolones have similar anaerobic activity is incorrect; they vary significantly 2
Inadequate dosing: When levofloxacin is used in combination therapy for mixed infections, ensure adequate dosing (750mg may be preferred over 500mg for certain infections) 4, 5
In summary, while levofloxacin has good activity against many aerobic gram-positive and gram-negative bacteria, its limited anaerobic coverage means it should not be relied upon as monotherapy when treating infections with significant anaerobic involvement.